Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
Trading Window for the Designated Persons of the Company shall remain closed w.e.f 01st January, 2024 and shall reopen after 48 hours of declaration of unaudited financial results for the third quarter and nine months ended December, 31 2023. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for Unaudited Financial Results for the quarter and the half year ended September 30, 2023 Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Financial Results for the Second Quarter and Half Year Ended 30th September,2023 duly approved by the Audit Committee and Board Meeting in its meeting held on November 11, 2023 Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for The Board Meeting To Be Held On Saturday, November 11, 2023 To Consider And Approve Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 ,inter alia, to consider and approve Standalone Unaudited Financial Results for the quarter and half year ended as on September 30, 2023 Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation Under Regulation 30-Reconstitution Of Nomination & Remuneration Committee By Appointing Mr. Manas Mengar Non-Executive & Independent Director As The Member Of These Committee By Circular Resolution Of BOD
Reconstitution of Nomination & Remuneration Committee by appointing Mr. Manas Mengar (DIN:1021806), Non-executive and Independent Director of the Company w.e.f 17th October,2023 as the member of these Committee by way of Circular Resolution passed by the members of Board of Directors Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants)Regulation, 2018 for the quarter ended September 30, 2023. Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
Intimation of Closure of Trading Window for the quarter and half year ended September 30, 2023. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Directorate
Mr. Subhash Salunke (DIN:07940567), Non-executive and Independent Director of the Company has attained age of 75 years and on the completion of his term as approved by members by Special Resolution till September, 28 2023. Consequently he ceases to be Non-executive Independent Director/Member of Audit Committee and Nomination & Remuneration Committee with the effect from the closure of business hours on September 28, 2023. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Manas Mengar (DIN:10218206)as the Non-Executive and Independent Director of the Company for the period of five consecutive years. Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting results along with the Scrutinizer''s report of the 50th Annual General Meeting held on September 26, 2023